4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0000950170-24-141597
Chief Financial Officer sold 4,865 shares at an average $4.42 ($21,491)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Catinazzo Thomas · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-27 | Sale : show line 1 in the form 10b5-1 | −299 | $4.38 | $1,310 | 303,792 | D |
| 2024-12-27 | Sale : show line 2 in the form 10b5-1 | −4,566 | $4.42 | $20,182 | 299,226 | D |
| Open-market sales · 4,865 sh · avg $4.42 · $21,491 | ||||||
Loading xslF345X05/ownership.xml…